XCEL BRANDS INC (XELB) Fundamental Analysis & Valuation

NASDAQ:XELB • US98400M2008

1.48 USD
+0.02 (+1.37%)
Last: Mar 10, 2026, 03:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This XELB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to XELB. XELB was compared to 124 industry peers in the Specialty Retail industry. XELB has a bad profitability rating. Also its financial health evaluation is rather negative. XELB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. XELB Profitability Analysis

1.1 Basic Checks

  • XELB had negative earnings in the past year.
  • XELB had a negative operating cash flow in the past year.
  • In the past 5 years XELB always reported negative net income.
  • XELB had negative operating cash flow in 4 of the past 5 years.
XELB Yearly Net Income VS EBIT VS OCF VS FCFXELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • XELB has a Return On Assets of -53.80%. This is amonst the worse of the industry: XELB underperforms 89.52% of its industry peers.
  • XELB has a worse Return On Equity (-116.41%) than 71.77% of its industry peers.
Industry RankSector Rank
ROA -53.8%
ROE -116.41%
ROIC N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
XELB Yearly ROA, ROE, ROICXELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • XELB has a Gross Margin of 156.91%. This is amongst the best in the industry. XELB outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of XELB has grown nicely.
  • XELB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 156.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
XELB Yearly Profit, Operating, Gross MarginsXELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. XELB Health Analysis

2.1 Basic Checks

  • XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XELB has less shares outstanding than it did 1 year ago.
  • XELB has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for XELB is higher compared to a year ago.
XELB Yearly Shares OutstandingXELB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
XELB Yearly Total Debt VS Total AssetsXELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • XELB has an Altman-Z score of -3.54. This is a bad value and indicates that XELB is not financially healthy and even has some risk of bankruptcy.
  • XELB has a worse Altman-Z score (-3.54) than 86.29% of its industry peers.
  • A Debt/Equity ratio of 0.48 indicates that XELB is not too dependend on debt financing.
  • The Debt to Equity ratio of XELB (0.48) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -3.54
ROIC/WACCN/A
WACC10.38%
XELB Yearly LT Debt VS Equity VS FCFXELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that XELB may have some problems paying its short term obligations.
  • With a Current ratio value of 0.51, XELB is not doing good in the industry: 89.52% of the companies in the same industry are doing better.
  • XELB has a Quick Ratio of 0.51. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • XELB's Quick ratio of 0.51 is in line compared to the rest of the industry. XELB outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
XELB Yearly Current Assets VS Current LiabilitesXELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. XELB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.50% over the past year.
  • XELB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -46.66%.
  • XELB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -27.67% yearly.
EPS 1Y (TTM)50.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.33%
Revenue 1Y (TTM)-46.66%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-41.53%

3.2 Future

  • Based on estimates for the next years, XELB will show a small growth in Earnings Per Share. The EPS will grow by 3.79% on average per year.
  • Based on estimates for the next years, XELB will show a decrease in Revenue. The Revenue will decrease by -9.31% on average per year.
EPS Next Y-41.64%
EPS Next 2Y4.25%
EPS Next 3Y3.79%
EPS Next 5YN/A
Revenue Next Year-40.58%
Revenue Next 2Y4.54%
Revenue Next 3Y-9.31%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XELB Yearly Revenue VS EstimatesXELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
XELB Yearly EPS VS EstimatesXELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. XELB Valuation Analysis

4.1 Price/Earnings Ratio

  • XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year XELB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XELB Price Earnings VS Forward Price EarningsXELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XELB Per share dataXELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.25%
EPS Next 3Y3.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XELB Dividend Analysis

5.1 Amount

  • XELB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XELB Fundamentals: All Metrics, Ratios and Statistics

XCEL BRANDS INC

NASDAQ:XELB (3/10/2026, 3:14:49 PM)

1.48

+0.02 (+1.37%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-19
Earnings (Next)05-26
Inst Owners14.25%
Inst Owner Change88.3%
Ins Owners29.37%
Ins Owner Change5.21%
Market Cap8.72M
Revenue(TTM)4.98M
Net Income(TTM)-21.77M
Analysts82.5
Price Target5.1 (244.59%)
Short Float %1.82%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.25%
Min EPS beat(2)27.45%
Max EPS beat(2)53.05%
EPS beat(4)3
Avg EPS beat(4)26.48%
Min EPS beat(4)-3.39%
Max EPS beat(4)53.05%
EPS beat(8)7
Avg EPS beat(8)38.16%
EPS beat(12)9
Avg EPS beat(12)26.68%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.64%
Min Revenue beat(2)-29.58%
Max Revenue beat(2)-11.69%
Revenue beat(4)0
Avg Revenue beat(4)-30.53%
Min Revenue beat(4)-43.05%
Max Revenue beat(4)-11.69%
Revenue beat(8)1
Avg Revenue beat(8)-17.21%
Revenue beat(12)3
Avg Revenue beat(12)-9.18%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.75
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.98
EYN/A
EPS(NY)-2.09
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-1.12
OCFYN/A
SpS0.85
BVpS3.17
TBVpS-2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.8%
ROE -116.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 156.91%
FCFM N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
F-Score2
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.28%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z -3.54
F-Score2
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)2.47%
Cap/Depr(5y)7.52%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.33%
EPS Next Y-41.64%
EPS Next 2Y4.25%
EPS Next 3Y3.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-46.66%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-41.53%
Revenue Next Year-40.58%
Revenue Next 2Y4.54%
Revenue Next 3Y-9.31%
Revenue Next 5YN/A
EBIT growth 1Y37.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.6%
EBIT Next 3Y27.18%
EBIT Next 5YN/A
FCF growth 1Y-8.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.82%
OCF growth 3YN/A
OCF growth 5YN/A

XCEL BRANDS INC / XELB FAQ

What is the fundamental rating for XELB stock?

ChartMill assigns a fundamental rating of 1 / 10 to XELB.


What is the valuation status for XELB stock?

ChartMill assigns a valuation rating of 0 / 10 to XCEL BRANDS INC (XELB). This can be considered as Overvalued.


What is the profitability of XELB stock?

XCEL BRANDS INC (XELB) has a profitability rating of 1 / 10.


What is the earnings growth outlook for XCEL BRANDS INC?

The Earnings per Share (EPS) of XCEL BRANDS INC (XELB) is expected to decline by -41.64% in the next year.